Andrew Bell

3.2k citations

72 papers · 2.4k indexed · 1 hit paper · h-index 27

Organic Chemistry top 1%
Molecular Biology
Public Health, Environmental and Occupational Health top 10%
Inorganic Chemistry top 5%
Epidemiology

Co-authors: David Brown Peter Ellis N.K. Terrett Dino Amoroso Nicolas Marion Steven P. Nolan Oscar Navarro Edward W. Tate
Topics: Organometallic Complex Synthesis and Catalysis (15 papers)Synthetic Organic Chemistry Methods (11 papers)Catalytic Cross-Coupling Reactions (10 papers)
Cited by: Organic Chemistry Process Chemistry and Technology Inorganic Chemistry
Journals: Journal of the American Chemical Society Chemistry of Materials ACS Applied Materials & Interfaces
Partner nations: United Kingdom United States Canada

In The Last Decade

Andrew Bell

70 papers receiving 2.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Sildenafil (VIAGRATM), a potent and selective inhibitor of type 5 cGMP phosphodiesterase with utility for the treatment of male erectile dysfunction

1996 516 citations Andrew Bell, Peter Ellis et al. Bioorganic & Medicinal Chemistry Letters profile →

Peers

Countries citing papers authored by Andrew Bell

Since Specialization

Citations

This map shows the geographic impact of Andrew Bell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew Bell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew Bell more than expected).

Fields of papers citing papers by Andrew Bell

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrew Bell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew Bell. The network helps show where Andrew Bell may publish in the future.

Co-authorship network of co-authors of Andrew Bell

This figure shows the co-authorship network connecting the top 25 collaborators of Andrew Bell. A scholar is included among the top collaborators of Andrew Bell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrew Bell. Andrew Bell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	MYC deregulation sensitizes cancer cells to N-myristoyltransferase inhibition 2025 ·Cell Reports ·(unknown),James Zhang,Monica Faronato,(unknown),Wouter W. Kallemeijn,Francesco Falciani,Josephine Walton,(unknown),Samuele Vannini,Evon Poon,Barbara Martins Da Costa,Roberto Solari,Robin A. E. Carr,Andrew Bell,Edward Bartlett,(unknown),Martin Janz,Louis Chesler,Dinis Pedro Calado,Edward W. Tate	0
2	Structure of Plasmodium vivax N-myristoyltransferase with inhibitor IMP-1088: exploring an NMT inhibitor for antimalarial therapy 2024 ·Acta Crystallographica Section F Structural Biology Communications ·(unknown),(unknown),(unknown),(unknown),Bart L. Staker,(unknown),(unknown),Stephen J. Mayclin,Jan Abendroth,Donald D. Lorimer,Thomas E. Edwards,Edward W. Tate,Sandhya Subramanian,Andrew Bell,Peter J. Myler,Oluwatoyin A. Asojo,(unknown)	0
3	Structure-Guided Identification of Resistance Breaking Antimalarial N‑Myristoyltransferase Inhibitors 2019 ·Cell chemical biology ·Anja Schlott,Stephen J. Mayclin,(unknown),Olivia Coburn‐Flynn,Andrew Bell,Judith L. Green,Ellen Knuepfer,(unknown),Roger V. Bonnert,Brice Campo,Jeremy N. Burrows,(unknown),Bart L. Staker,Chun‐wa Chung,Peter J. Myler,David A. Fidock,Edward W. Tate,Anthony A. Holder	24
4	Fragment-derived inhibitors of human N-myristoyltransferase block capsid assembly and replication of the common cold virus 2018 ·Nature Chemistry ·Aurélie Mousnier,Andrew Bell,Dawid Swieboda,Julia Morales‐Sanfrutos,Inmaculada Pérez‐Dorado,J.A. Brannigan,Joseph Newman,Markus Ritzefeld,(unknown),Anabel Guedán,Amin S. Asfor,Sean W. Robinson,(unknown),Anthony J. Wilkinson,Sebastian L. Johnston,Robin J. Leatherbarrow,Tobias J. Tuthill,Roberto Solari,Edward W. Tate	90
5	High Throughput Screening Identifies Novel Lead Compounds with Activity against Larval, Juvenile and Adult Schistosoma mansoni 2016 ·PLoS neglected tropical diseases ·Nuha R. Mansour,Ross A. Paveley,Mark Gardner,Andrew Bell,Tanya Parkinson,Q. D. Bickle	33
6	Plate-based diversity subset screening generation 2: an improved paradigm for high-throughput screening of large compound files 2016 ·Molecular Diversity ·Andrew Bell,Joseph Bradley,Jeremy R. Everett,Jens Loesel,(unknown),James E. Mills,Marie‐Claire Peakman,Robert E. Sharp,Christine A. Williams,Hongyao Zhu	3
7	Using a Non-Image-Based Medium-Throughput Assay for Screening Compounds Targeting N-myristoylation in Intracellular Leishmania Amastigotes 2014 ·PLoS neglected tropical diseases ·Daniel Paape,Andrew Bell,William P. Heal,(unknown),Robin J. Leatherbarrow,Edward W. Tate,Deborah F. Smith	15
8	Diverse modes of binding in structures ofLeishmania majorN-myristoyltransferase with selective inhibitors 2014 ·IUCrJ ·J.A. Brannigan,S.M. Roberts,Andrew Bell,(unknown),Michael R. Hodgkinson,Edward W. Tate,Robin J. Leatherbarrow,Deborah F. Smith,Anthony J. Wilkinson	31
9	Plate-based diversity subset screening: an efficient paradigm for high throughput screening of a large screening file 2013 ·Molecular Diversity ·Andrew Bell,Joseph Bradley,Jeremy R. Everett,Michelle Knight,Jens Loesel,John P. Mathias,(unknown),James E. Mills,Robert E. Sharp,Christine A. Williams,(unknown)	5
10	N-Myristoyltransferase as a potential drug target in malaria and leishmaniasis 2013 ·Parasitology ·Edward W. Tate,Andrew Bell,M.D. Rackham,Megan H. Wright	56
11	Challenges of drug discovery in novel target space. The discovery and evaluation of PF-3893787: A novel histamine H4 receptor antagonist 2011 ·Bioorganic & Medicinal Chemistry Letters ·Charles E. Mowbray,Andrew Bell,(unknown),Michelle A. Collins,Rhys Jones,(unknown),(unknown),(unknown),Michael Paradowski,Emanuel Schenck,(unknown),Nigel A. Swain,D. H. Williams	29
12	Discovery of a series of potent and selective human H4 antagonists using ligand efficiency and libraries to explore structure–activity relationship (SAR) 2011 ·Bioorganic & Medicinal Chemistry Letters ·(unknown),Matthew D. Selby,Andrew Bell,Andrew C. Mansfield,Mark Gardner,G. Smith,(unknown),(unknown),(unknown),Rhys Jones,(unknown),Christopher D. Brown,(unknown),(unknown),Charles E. Mowbray	4
13	The discovery of potent, selective, and orally bioavailable PDE9 inhibitors as potential hypoglycemic agents 2009 ·Bioorganic & Medicinal Chemistry Letters ·Michael P. DeNinno,(unknown),Andrew Bell,Yue Chen,(unknown),(unknown),John B. Etienne,Dianna E. Moore,Michael Palmer,Michael Visser,(unknown),William J. Zavadoski,E. Michael Gibbs	32
14	4,4,5,5‐Tetraphenyl‐1,3,2‐dioxaborolane: A Bulky Borane for the Transition Metal Catalysed Hydroboration of Alkenes 2007 ·European Journal of Inorganic Chemistry ·(unknown),(unknown),Christopher M. Vogels,Michael P. Shaver,A. Decken,Andrew Bell,Stephen A. Westcott	21
15	Scope of the directed dihydroxylation: application to cyclic homoallylic alcohols and trihaloacetamides 2003 ·Organic & Biomolecular Chemistry ·Timothy J. Donohoe,(unknown),Michael J. Waring,Madeleine Helliwell,Andrew Bell,Nicholas J. Newcombe	30
16	Analysis of Meningococcal Serogroup C-Specific Antibody Levels in British Columbian Children and Adolescents 1996 ·The Journal of Infectious Diseases ·Leslie A. Mitchell,J Ochnio,(unknown),(unknown),Margaret Kay Ho,Andrew Bell	32
17	2(1H)-Quinolinones with cardiac stimulant activity. 2. Synthesis and biological activities of 6-(N-linked, five-membered heteroaryl) derivatives 1989 ·Journal of Medicinal Chemistry ·(unknown),Andrew Bell,Simon F. Campbell,Peter Ellis,(unknown),David S. Morris,D. Allen Roberts,(unknown),(unknown),Mark H. Stefaniak	39
18	2(1H)-Quinolinones with cardiac stimulant activity. 3. Synthesis and biological properties of 6-imidazol-1-yl derivatives 1989 ·Journal of Medicinal Chemistry ·Andrew Bell,Simon F. Campbell,David S. Morris,David A. Roberts,Mark H. Stefaniak	13
19	7-Heteroaryl-1,2,3,5-tetrahydroimidazol[2,1-b]quinazolin-2(1H)-one derivatives with cardiac stimulant activity 1989 ·Journal of Medicinal Chemistry ·Andrew Bell,Simon F. Campbell,D. Allen Roberts,(unknown)	9
20	2(1H)-Quinolinones with cardiac stimulant activity. 1. Synthesis and biological activities of (six-membered heteroaryl)-substituted derivatives 1988 ·Journal of Medicinal Chemistry ·(unknown),Andrew Bell,Simon F. Campbell,Peter Ellis,(unknown),David A. Roberts,(unknown),(unknown),Mark H. Stefaniak	44

About Andrew Bell

Andrew Bell is a scholar working on Organic Chemistry, Process Chemistry and Technology and Small Animals, having authored 72 papers that have together received 2.4k indexed citations. Recurring topics across this work include Organometallic Complex Synthesis and Catalysis (15 papers), Synthetic Organic Chemistry Methods (11 papers) and Catalytic Cross-Coupling Reactions (10 papers). The work is most often cited by research in Organic Chemistry (1.4k citations), Process Chemistry and Technology (54 citations) and Inorganic Chemistry (233 citations). Andrew Bell has collaborated with scholars based in United Kingdom, United States and Canada. Frequent co-authors include David Brown, Peter Ellis, N.K. Terrett, Dino Amoroso, Nicolas Marion, Steven P. Nolan, Oscar Navarro, Edward W. Tate, Richard A. Register and Robin J. Leatherbarrow. Their work appears in journals such as Journal of the American Chemical Society, Chemistry of Materials and ACS Applied Materials & Interfaces.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact